Search results for: 'Global, Budgeting, Testing and Regulations for Autonomous Driving Solutions'
- Related search terms
- forging AND Casting
- Regulations and Evolving Markets Drive Growth in the Quality Management Software Industry\
- AND 6153=5227-- cSlQ
- Regulations and Evolving Markets Drive Growth in the Quality Management Software
- solutions to meet the challenges of urbanization and promote the intelligent transformation of transportation. The system is bas
-
27 Nov 2024  |  Global  |  Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
Gen AI-based Solutions are Driving Transformational Growth across the Payer and Provider Ecosystem as Organizations Move from Identification to Implementation
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journey. Gen AI seamlessly syncs with existing tools/IT ...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Jun 2019  |  Asia Pacific  |  Market Research
Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023
The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market
This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...
$3,000.00
Special Price $2,250.00 save 25 %
-
11 Nov 2015  |  Asia Pacific  |  Market Research
Asia-Pacific Point-of-Care Testing Market
Trends, Challenges, and Best Practices for Stakeholders
Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Feb 2014  |  North America  |  Market Research
US and European Sleep Disorder Diagnostic Devices Market
Cost-effective Solutions in Home Sleep Tests Stir Market Growth
This research service studies the qualitative and the quantitative aspects of the sleep disorder diagnostic devices market in Europe and the United States. The study includes clinical polysomnogram (PSG) systems and ambulatory PSG systems. The countries in this research include: Germany, France, Italy, Spain, the United Kingdom, the United States, ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2016  |  North America  |  Market Research
Growth Opportunities in the US Point-of-care Testing Market
Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Feb 2023  |  North America  |  Market Research
Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities
Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions
Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jun 2024  |  Global  |  Market Research
Remote Patient Monitoring Sector Driving Transformational Growth through Strategic Partnerships: Forecast Global, 2024 2028
Industry Convergence and Digitalization Intensify the Competitive Environment
Remote patient monitoring (RPM) encompasses devices and IT infrastructure designed to enable clinicians to collect and monitor patients' biometric data and behaviors remotely. This infrastructure includes software, gateways, platforms, data transmission and management systems, and networks. While consumer-grade wearables, including smartphones, sma...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Sep 2015  |  North America  |  Market Research
Product and Pipeline Analysis of the Global Colorectal Cancer Market
Targeted Therapeutics and Immunology Combine to Take Colorectal Cancer Treatments to the Next Level
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...
$3,950.00
Special Price $2,962.50 save 25 %
-
30 Jun 2021  |  North America  |  Market Research
US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities
Telegenetic Counseling to Revolutionize Access to Patient Care
In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...
$2,450.00
Special Price $1,837.50 save 25 %